| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Integrins | 56 | 2019 | 843 | 4.660 |
Why?
|
| Antigens, CD | 53 | 2015 | 4032 | 4.380 |
Why?
|
| Receptors, Very Late Antigen | 41 | 1997 | 74 | 2.430 |
Why?
|
| Membrane Glycoproteins | 30 | 2012 | 3713 | 2.060 |
Why?
|
| Cell Adhesion | 59 | 2011 | 3102 | 1.910 |
Why?
|
| Membrane Proteins | 37 | 2015 | 7885 | 1.850 |
Why?
|
| Acyltransferases | 4 | 2020 | 306 | 1.750 |
Why?
|
| Integrin alpha6beta4 | 9 | 2013 | 30 | 1.720 |
Why?
|
| Integrin alpha3beta1 | 16 | 2010 | 53 | 1.390 |
Why?
|
| Antigens, Surface | 33 | 2004 | 1616 | 1.260 |
Why?
|
| Cell Adhesion Molecules | 25 | 2010 | 1614 | 1.120 |
Why?
|
| Membrane Microdomains | 6 | 2008 | 205 | 0.950 |
Why?
|
| Palmitic Acid | 5 | 2008 | 149 | 0.890 |
Why?
|
| Receptors, Lymphocyte Homing | 7 | 1997 | 141 | 0.730 |
Why?
|
| Laminin | 10 | 2019 | 406 | 0.720 |
Why?
|
| Fibronectins | 21 | 2009 | 724 | 0.720 |
Why?
|
| Integrin alpha6 | 2 | 2012 | 30 | 0.710 |
Why?
|
| Tumor Cells, Cultured | 31 | 2012 | 6131 | 0.700 |
Why?
|
| Lipoylation | 2 | 2012 | 87 | 0.670 |
Why?
|
| Platelet Membrane Glycoproteins | 7 | 2000 | 283 | 0.630 |
Why?
|
| Immunoglobulins | 5 | 2009 | 855 | 0.580 |
Why?
|
| Amino Acid Sequence | 42 | 2007 | 13427 | 0.570 |
Why?
|
| Protein Binding | 24 | 2011 | 9344 | 0.570 |
Why?
|
| Cell Line | 57 | 2008 | 15604 | 0.570 |
Why?
|
| Integrin alpha6beta1 | 5 | 2003 | 19 | 0.560 |
Why?
|
| Avian Proteins | 3 | 2004 | 78 | 0.540 |
Why?
|
| Cytoplasm | 12 | 2008 | 1505 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 53 | 2010 | 9264 | 0.510 |
Why?
|
| Molecular Sequence Data | 39 | 2007 | 17629 | 0.500 |
Why?
|
| Antigens, Neoplasm | 5 | 2004 | 2001 | 0.490 |
Why?
|
| Integrin alpha4beta1 | 9 | 2003 | 119 | 0.480 |
Why?
|
| Enzyme Stability | 2 | 2012 | 219 | 0.470 |
Why?
|
| Cysteine | 5 | 2007 | 897 | 0.460 |
Why?
|
| Cell Movement | 15 | 2015 | 5216 | 0.460 |
Why?
|
| Macromolecular Substances | 19 | 2004 | 1435 | 0.450 |
Why?
|
| Caveolins | 2 | 2004 | 102 | 0.450 |
Why?
|
| Kangai-1 Protein | 3 | 2011 | 22 | 0.450 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2013 | 2848 | 0.430 |
Why?
|
| Cricetinae | 17 | 2001 | 2423 | 0.430 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 16 | 1997 | 692 | 0.420 |
Why?
|
| Cell Line, Tumor | 16 | 2020 | 17173 | 0.420 |
Why?
|
| Antioxidants | 1 | 2020 | 1673 | 0.410 |
Why?
|
| Collagen | 14 | 2002 | 2646 | 0.400 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2004 | 146 | 0.400 |
Why?
|
| Protein Structure, Tertiary | 10 | 2011 | 3775 | 0.390 |
Why?
|
| Receptors, Immunologic | 15 | 1991 | 1418 | 0.390 |
Why?
|
| Precipitin Tests | 14 | 2002 | 816 | 0.390 |
Why?
|
| Extracellular Matrix | 12 | 2011 | 1739 | 0.390 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 3 | 2000 | 59 | 0.380 |
Why?
|
| Blood Proteins | 3 | 2004 | 1191 | 0.380 |
Why?
|
| Recombinant Fusion Proteins | 17 | 2004 | 3744 | 0.370 |
Why?
|
| ADAM Proteins | 2 | 2011 | 243 | 0.370 |
Why?
|
| Animals | 95 | 2017 | 169335 | 0.370 |
Why?
|
| Antigens, Differentiation | 8 | 1989 | 921 | 0.370 |
Why?
|
| Apoptosis | 5 | 2020 | 9527 | 0.360 |
Why?
|
| Cell Proliferation | 7 | 2017 | 10486 | 0.360 |
Why?
|
| beta Catenin | 2 | 2013 | 1047 | 0.360 |
Why?
|
| Manganese | 7 | 1998 | 394 | 0.350 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 4926 | 0.340 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 185 | 0.330 |
Why?
|
| CHO Cells | 13 | 2001 | 1379 | 0.330 |
Why?
|
| Protein Conformation | 19 | 2005 | 3956 | 0.320 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2009 | 59 | 0.320 |
Why?
|
| Signal Transduction | 17 | 2015 | 23653 | 0.320 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2011 | 614 | 0.310 |
Why?
|
| RNA Interference | 6 | 2020 | 2835 | 0.310 |
Why?
|
| Transfection | 21 | 2002 | 5763 | 0.300 |
Why?
|
| T-Lymphocytes | 24 | 2003 | 10276 | 0.300 |
Why?
|
| Ligands | 14 | 2003 | 3283 | 0.300 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 21188 | 0.290 |
Why?
|
| Epitopes | 18 | 2002 | 2529 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2013 | 4064 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 2004 | 0.280 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3139 | 0.260 |
Why?
|
| Cross-Linking Reagents | 6 | 2007 | 692 | 0.260 |
Why?
|
| Camptothecin | 2 | 2020 | 600 | 0.260 |
Why?
|
| Mice, SCID | 3 | 2017 | 2631 | 0.260 |
Why?
|
| Cations, Divalent | 6 | 1998 | 167 | 0.260 |
Why?
|
| Adhesins, Bacterial | 2 | 1998 | 118 | 0.260 |
Why?
|
| Palmitates | 2 | 2004 | 70 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2011 | 1683 | 0.250 |
Why?
|
| Humans | 146 | 2020 | 768970 | 0.240 |
Why?
|
| Mice | 46 | 2017 | 82072 | 0.240 |
Why?
|
| Mice, Nude | 7 | 2017 | 3631 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1064 | 0.230 |
Why?
|
| Protein Interaction Mapping | 2 | 2007 | 621 | 0.230 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2017 | 122 | 0.230 |
Why?
|
| Palmitic Acids | 1 | 2004 | 53 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2012 | 2474 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 7 | 1980 | 318 | 0.230 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2009 | 462 | 0.220 |
Why?
|
| Neoplasms | 5 | 2019 | 22389 | 0.220 |
Why?
|
| Neoplasm Proteins | 6 | 2006 | 3608 | 0.220 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 1116 | 0.220 |
Why?
|
| Receptors, Cell Surface | 7 | 2003 | 2820 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5342 | 0.220 |
Why?
|
| Blotting, Western | 8 | 2012 | 5033 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13698 | 0.220 |
Why?
|
| Cell Membrane | 9 | 2006 | 3659 | 0.210 |
Why?
|
| Cell Membrane Structures | 1 | 2003 | 24 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5864 | 0.210 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2009 | 1966 | 0.210 |
Why?
|
| Receptor, erbB-2 | 2 | 2012 | 2606 | 0.210 |
Why?
|
| Base Sequence | 15 | 2008 | 12430 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2812 | 0.200 |
Why?
|
| Cytoskeleton | 3 | 2006 | 1179 | 0.200 |
Why?
|
| Lymphocyte Activation | 16 | 1991 | 5505 | 0.200 |
Why?
|
| Kidney Diseases | 1 | 2013 | 2100 | 0.200 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 6 | 2001 | 896 | 0.200 |
Why?
|
| Enterovirus B, Human | 4 | 1994 | 49 | 0.190 |
Why?
|
| Molecular Weight | 18 | 1996 | 2173 | 0.190 |
Why?
|
| HEK293 Cells | 3 | 2017 | 4290 | 0.190 |
Why?
|
| Neoplasm Transplantation | 4 | 2015 | 2018 | 0.190 |
Why?
|
| Receptors, Fibronectin | 9 | 1996 | 37 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 2634 | 0.180 |
Why?
|
| Cell Aggregation | 5 | 1993 | 238 | 0.180 |
Why?
|
| Integrin alpha4 | 7 | 1997 | 88 | 0.180 |
Why?
|
| Cell Size | 2 | 2002 | 626 | 0.180 |
Why?
|
| Cloning, Molecular | 9 | 2005 | 4168 | 0.170 |
Why?
|
| Sequence Deletion | 7 | 2002 | 1498 | 0.170 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2001 | 303 | 0.170 |
Why?
|
| Plant Oils | 1 | 2000 | 199 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2012 | 8317 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 3 | 1993 | 835 | 0.170 |
Why?
|
| Protein Kinase C | 2 | 2001 | 1207 | 0.170 |
Why?
|
| Receptors, Collagen | 7 | 1995 | 25 | 0.160 |
Why?
|
| Flow Cytometry | 17 | 2012 | 5906 | 0.160 |
Why?
|
| Receptors, Virus | 4 | 1999 | 652 | 0.160 |
Why?
|
| Enzyme Activation | 5 | 2010 | 3588 | 0.150 |
Why?
|
| Dimerization | 3 | 2005 | 886 | 0.150 |
Why?
|
| Integrin alpha Chains | 3 | 2012 | 93 | 0.150 |
Why?
|
| Neurites | 1 | 2000 | 390 | 0.150 |
Why?
|
| K562 Cells | 3 | 2011 | 648 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3629 | 0.150 |
Why?
|
| Cells, Cultured | 12 | 2011 | 19023 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 4413 | 0.150 |
Why?
|
| Rhabdomyosarcoma | 4 | 1996 | 358 | 0.150 |
Why?
|
| Prostaglandins | 4 | 1980 | 398 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2001 | 567 | 0.140 |
Why?
|
| Mutagenesis | 2 | 2001 | 1229 | 0.140 |
Why?
|
| 3T3 Cells | 4 | 2003 | 1085 | 0.140 |
Why?
|
| Leukocytes | 4 | 1995 | 2034 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2005 | 2749 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2238 | 0.140 |
Why?
|
| Integrin alpha3 | 4 | 2001 | 26 | 0.140 |
Why?
|
| Carrier Proteins | 3 | 1999 | 4939 | 0.140 |
Why?
|
| Magnesium | 3 | 1995 | 816 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 1999 | 1328 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 2 | 2011 | 426 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2001 | 1231 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1608 | 0.130 |
Why?
|
| Melanoma | 1 | 2015 | 5709 | 0.130 |
Why?
|
| Structure-Activity Relationship | 7 | 1997 | 3057 | 0.130 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 660 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 5 | 1995 | 826 | 0.130 |
Why?
|
| Peptide Fragments | 7 | 2002 | 5151 | 0.120 |
Why?
|
| Recombinant Proteins | 8 | 1998 | 6512 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2000 | 1731 | 0.120 |
Why?
|
| Proteins | 4 | 2008 | 6011 | 0.120 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 2395 | 0.120 |
Why?
|
| Receptors, Laminin | 5 | 1995 | 26 | 0.120 |
Why?
|
| Dioxoles | 1 | 2015 | 96 | 0.120 |
Why?
|
| Kinetics | 10 | 1996 | 6332 | 0.120 |
Why?
|
| Octoxynol | 3 | 2002 | 76 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 434 | 0.120 |
Why?
|
| Multigene Family | 3 | 2000 | 1082 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 3433 | 0.120 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1996 | 430 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 1999 | 4978 | 0.110 |
Why?
|
| Cell Line, Transformed | 3 | 2012 | 867 | 0.110 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2012 | 100 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1996 | 4528 | 0.110 |
Why?
|
| Integrin beta Chains | 1 | 1994 | 115 | 0.110 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2015 | 200 | 0.110 |
Why?
|
| Binding Sites | 7 | 2003 | 6023 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2001 | 2911 | 0.110 |
Why?
|
| Receptors, Peptide | 2 | 1996 | 280 | 0.110 |
Why?
|
| Enzyme Induction | 2 | 2004 | 455 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2009 | 3525 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 306 | 0.110 |
Why?
|
| Proteomics | 1 | 2007 | 3914 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 1997 | 564 | 0.110 |
Why?
|
| Frizzled Receptors | 1 | 2013 | 91 | 0.110 |
Why?
|
| Mice, Knockout | 5 | 2012 | 14484 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 1988 | 1027 | 0.110 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1998 | 176 | 0.100 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 58 | 0.100 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2012 | 12 | 0.100 |
Why?
|
| Peroxides | 4 | 1980 | 76 | 0.100 |
Why?
|
| Fibroblasts | 6 | 2012 | 4179 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2007 | 997 | 0.100 |
Why?
|
| Caveolin 1 | 2 | 2004 | 255 | 0.100 |
Why?
|
| Mutation | 11 | 2011 | 30266 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 8 | 1996 | 3408 | 0.100 |
Why?
|
| Fibrosarcoma | 3 | 2001 | 313 | 0.100 |
Why?
|
| Receptors, Antigen | 2 | 1989 | 51 | 0.100 |
Why?
|
| Transcellular Cell Migration | 1 | 2011 | 3 | 0.100 |
Why?
|
| Models, Biological | 6 | 2008 | 9499 | 0.100 |
Why?
|
| U937 Cells | 1 | 2011 | 260 | 0.090 |
Why?
|
| Cell Differentiation | 6 | 2002 | 11684 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2011 | 108 | 0.090 |
Why?
|
| Amino Acid Motifs | 2 | 2005 | 930 | 0.090 |
Why?
|
| Glycoproteins | 3 | 1993 | 2202 | 0.090 |
Why?
|
| HeLa Cells | 4 | 2009 | 3076 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 11932 | 0.090 |
Why?
|
| Carcinogens | 1 | 2012 | 453 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2005 | 1162 | 0.080 |
Why?
|
| Peptides | 5 | 1998 | 4353 | 0.080 |
Why?
|
| Glycosylation | 2 | 2004 | 1101 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 506 | 0.080 |
Why?
|
| Calcium | 4 | 1995 | 5792 | 0.080 |
Why?
|
| Extracellular Space | 2 | 2002 | 565 | 0.080 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 697 | 0.080 |
Why?
|
| Solubility | 3 | 1998 | 1087 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 725 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1705 | 0.080 |
Why?
|
| Seminal Vesicles | 3 | 1978 | 103 | 0.080 |
Why?
|
| Benzamides | 1 | 2015 | 1387 | 0.080 |
Why?
|
| Integrin beta4 | 2 | 2001 | 29 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2893 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 123 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 1493 | 0.080 |
Why?
|
| Bacterial Proteins | 3 | 1998 | 3840 | 0.080 |
Why?
|
| Disulfides | 2 | 2005 | 467 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 506 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 527 | 0.070 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 874 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 1988 | 110 | 0.070 |
Why?
|
| Transgenes | 1 | 2011 | 1016 | 0.070 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 559 | 0.070 |
Why?
|
| Oligopeptides | 4 | 1995 | 1194 | 0.070 |
Why?
|
| Antigens | 2 | 1984 | 1444 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22379 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2005 | 5404 | 0.070 |
Why?
|
| Jurkat Cells | 2 | 2001 | 739 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
| Blotting, Northern | 5 | 1992 | 1553 | 0.070 |
Why?
|
| Quinazolines | 2 | 2012 | 1373 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 2204 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2013 | 1505 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 202 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2019 | 12806 | 0.070 |
Why?
|
| Cell Communication | 2 | 2008 | 1660 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2002 | 1647 | 0.070 |
Why?
|
| B-Lymphocytes | 4 | 1992 | 4794 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2012 | 1337 | 0.070 |
Why?
|
| Integrin alpha2 | 2 | 1997 | 39 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 968 | 0.070 |
Why?
|
| Cricetulus | 2 | 2001 | 812 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3592 | 0.070 |
Why?
|
| Phytohemagglutinins | 4 | 1987 | 165 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2010 | 1762 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 874 | 0.060 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 69 | 0.060 |
Why?
|
| Neutrophils | 1 | 1998 | 3785 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 2 | 1977 | 265 | 0.060 |
Why?
|
| Genes | 1 | 1989 | 1824 | 0.060 |
Why?
|
| Actins | 2 | 2006 | 2065 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 1991 | 1142 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 1991 | 2574 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2008 | 2298 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 5 | 1987 | 564 | 0.060 |
Why?
|
| Cell Division | 6 | 1999 | 4478 | 0.060 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 1680 | 0.060 |
Why?
|
| Molecular Conformation | 2 | 2005 | 540 | 0.060 |
Why?
|
| Amino Sugars | 1 | 2004 | 39 | 0.060 |
Why?
|
| Binding Sites, Antibody | 4 | 1995 | 340 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2002 | 2179 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 1998 | 1658 | 0.060 |
Why?
|
| DNA | 9 | 1993 | 7214 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2004 | 120 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 1986 | 393 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 326 | 0.060 |
Why?
|
| Leucine | 1 | 2005 | 548 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 2942 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 368 | 0.050 |
Why?
|
| Leukemia, T-Cell | 1 | 2003 | 102 | 0.050 |
Why?
|
| Blood Platelets | 5 | 1988 | 2479 | 0.050 |
Why?
|
| DNA, Recombinant | 1 | 2003 | 455 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 505 | 0.050 |
Why?
|
| Immunosorbent Techniques | 3 | 1988 | 174 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 1985 | 1895 | 0.050 |
Why?
|
| Protein Transport | 1 | 2009 | 1956 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 7603 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2004 | 148 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 11230 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2006 | 641 | 0.050 |
Why?
|
| Prostaglandins G | 2 | 1979 | 2 | 0.050 |
Why?
|
| Mycoplasma | 1 | 1982 | 146 | 0.050 |
Why?
|
| Mycoplasma Infections | 1 | 1982 | 120 | 0.050 |
Why?
|
| Thymus Gland | 4 | 1995 | 1266 | 0.050 |
Why?
|
| Lysosomes | 1 | 2008 | 940 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 68 | 0.050 |
Why?
|
| Gels | 2 | 1995 | 423 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2009 | 8664 | 0.050 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2001 | 46 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2004 | 407 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 539 | 0.050 |
Why?
|
| Isoelectric Focusing | 4 | 1988 | 149 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 4124 | 0.050 |
Why?
|
| DNA Primers | 2 | 2008 | 2827 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 188 | 0.050 |
Why?
|
| COS Cells | 2 | 2001 | 1135 | 0.050 |
Why?
|
| Fertilization | 1 | 2003 | 197 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 672 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 665 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 298 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2004 | 393 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 598 | 0.050 |
Why?
|
| Endopeptidases | 3 | 1994 | 764 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2002 | 241 | 0.050 |
Why?
|
| Benzophenanthridines | 1 | 2001 | 27 | 0.050 |
Why?
|
| Phenanthridines | 1 | 2001 | 50 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 323 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2003 | 265 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 455 | 0.050 |
Why?
|
| Goats | 1 | 2001 | 166 | 0.050 |
Why?
|
| Genistein | 1 | 2001 | 87 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2683 | 0.050 |
Why?
|
| Astrocytes | 1 | 2009 | 1349 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 822 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3473 | 0.040 |
Why?
|
| Rats | 4 | 1998 | 23786 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 3621 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1990 | 0.040 |
Why?
|
| Magnetics | 1 | 2003 | 599 | 0.040 |
Why?
|
| Staurosporine | 1 | 2001 | 241 | 0.040 |
Why?
|
| Disease Progression | 2 | 2008 | 13674 | 0.040 |
Why?
|
| Growth Cones | 1 | 2000 | 117 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 2000 | 1197 | 0.040 |
Why?
|
| Alkaloids | 1 | 2001 | 192 | 0.040 |
Why?
|
| Desmin | 1 | 1999 | 99 | 0.040 |
Why?
|
| Dystroglycans | 1 | 1999 | 62 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2001 | 2682 | 0.040 |
Why?
|
| Prostaglandin Endoperoxides | 1 | 1978 | 12 | 0.040 |
Why?
|
| Female | 12 | 2020 | 397515 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2006 | 1344 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 839 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 240 | 0.040 |
Why?
|
| Giant Cells | 1 | 1999 | 187 | 0.040 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 1998 | 15 | 0.040 |
Why?
|
| Cell Fusion | 1 | 1999 | 294 | 0.040 |
Why?
|
| Yersinia | 1 | 1998 | 9 | 0.040 |
Why?
|
| Titrimetry | 1 | 1998 | 36 | 0.040 |
Why?
|
| Molecular Structure | 2 | 1996 | 1885 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11262 | 0.040 |
Why?
|
| Plasmids | 2 | 2002 | 2269 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 481 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2002 | 809 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1989 | 260 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 1057 | 0.040 |
Why?
|
| Schwann Cells | 1 | 1999 | 196 | 0.040 |
Why?
|
| Time Factors | 6 | 2003 | 40261 | 0.040 |
Why?
|
| Sodium Azide | 1 | 1997 | 24 | 0.040 |
Why?
|
| EF Hand Motifs | 1 | 1997 | 19 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1999 | 479 | 0.040 |
Why?
|
| Dystrophin | 1 | 1999 | 284 | 0.040 |
Why?
|
| Morphogenesis | 1 | 2002 | 747 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 1111 | 0.040 |
Why?
|
| Epitope Mapping | 2 | 1995 | 300 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2004 | 1024 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 2085 | 0.040 |
Why?
|
| Cytochalasin B | 1 | 1997 | 74 | 0.040 |
Why?
|
| Leukemia, Experimental | 2 | 1996 | 225 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1997 | 72 | 0.040 |
Why?
|
| Trypsin | 2 | 1988 | 491 | 0.040 |
Why?
|
| Serine | 1 | 2001 | 831 | 0.030 |
Why?
|
| Heme | 4 | 1980 | 316 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1982 | 1478 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 1999 | 407 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1751 | 0.030 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 1996 | 49 | 0.030 |
Why?
|
| Temperature | 1 | 2003 | 2235 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1998 | 385 | 0.030 |
Why?
|
| Chemical Precipitation | 4 | 1984 | 175 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 1990 | 1803 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 1248 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2067 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1997 | 278 | 0.030 |
Why?
|
| Mammals | 1 | 2001 | 1136 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2006 | 1595 | 0.030 |
Why?
|
| Interphase | 2 | 1988 | 227 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 1995 | 1065 | 0.030 |
Why?
|
| Endothelium, Vascular | 4 | 1995 | 4428 | 0.030 |
Why?
|
| Integrin alpha5 | 1 | 1995 | 21 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2002 | 2089 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1996 | 420 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1998 | 639 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 425 | 0.030 |
Why?
|
| Phylogeny | 1 | 2003 | 2843 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 1995 | 364 | 0.030 |
Why?
|
| Lung | 3 | 2012 | 10099 | 0.030 |
Why?
|
| Kidney | 2 | 2005 | 7058 | 0.030 |
Why?
|
| Digitonin | 1 | 1994 | 25 | 0.030 |
Why?
|
| Ionomycin | 1 | 1994 | 110 | 0.030 |
Why?
|
| Homeostasis | 2 | 2012 | 3347 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 1995 | 286 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 166 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1991 | 525 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 1995 | 2059 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 4785 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2674 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 30046 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1998 | 763 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 662 | 0.030 |
Why?
|
| Antibodies | 4 | 2004 | 2422 | 0.030 |
Why?
|
| Vitronectin | 1 | 1993 | 40 | 0.030 |
Why?
|
| Calpain | 1 | 1994 | 146 | 0.030 |
Why?
|
| Chickens | 1 | 1995 | 845 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 5707 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1983 | 342 | 0.030 |
Why?
|
| Point Mutation | 1 | 1998 | 1596 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 1742 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 706 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 892 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 1980 | 361 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 2488 | 0.030 |
Why?
|
| Butadienes | 1 | 2012 | 107 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2001 | 1469 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2012 | 120 | 0.020 |
Why?
|
| Male | 11 | 2020 | 365203 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2884 | 0.020 |
Why?
|
| Chemotaxis | 1 | 1995 | 600 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 10868 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2012 | 91 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13594 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2012 | 144 | 0.020 |
Why?
|
| Sequence Homology | 1 | 1992 | 199 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 2433 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2012 | 146 | 0.020 |
Why?
|
| Cholesterol | 1 | 2000 | 2913 | 0.020 |
Why?
|
| Self Tolerance | 1 | 2012 | 122 | 0.020 |
Why?
|
| Cell Survival | 2 | 1994 | 5793 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 1991 | 120 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 1992 | 363 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 493 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 6 | 1992 | 6232 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 849 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1986 | 3780 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 273 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1992 | 646 | 0.020 |
Why?
|
| Drosophila | 1 | 1998 | 1513 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 1952 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1133 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3726 | 0.020 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 2 | 1989 | 20 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 11116 | 0.020 |
Why?
|
| Receptors, Transferrin | 2 | 1992 | 300 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 1994 | 1083 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 299 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 543 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 213 | 0.020 |
Why?
|
| Glutathione Peroxidase | 2 | 1980 | 259 | 0.020 |
Why?
|
| Clone Cells | 5 | 1984 | 1670 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9618 | 0.020 |
Why?
|
| Arachidonic Acids | 2 | 1980 | 296 | 0.020 |
Why?
|
| Organ Specificity | 2 | 1991 | 1970 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3412 | 0.020 |
Why?
|
| Placenta | 2 | 1988 | 1725 | 0.020 |
Why?
|
| Cholic Acids | 1 | 1987 | 39 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1993 | 686 | 0.020 |
Why?
|
| Lipids | 1 | 1979 | 3345 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 1105 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1991 | 962 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1989 | 513 | 0.020 |
Why?
|
| Blood | 2 | 1988 | 599 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Epithelium | 2 | 1989 | 1607 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 2635 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1999 | 3702 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6086 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 990 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1997 | 4568 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2012 | 1252 | 0.020 |
Why?
|
| Chemistry | 2 | 1983 | 327 | 0.020 |
Why?
|
| Sheep | 2 | 1980 | 1451 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 12174 | 0.020 |
Why?
|
| Chemical Phenomena | 2 | 1983 | 486 | 0.020 |
Why?
|
| Phenols | 2 | 1980 | 526 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 610 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1993 | 1802 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2094 | 0.020 |
Why?
|
| Glycoside Hydrolases | 1 | 1985 | 135 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 162 | 0.020 |
Why?
|
| Artifacts | 1 | 1994 | 1942 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2452 | 0.020 |
Why?
|
| Rabbits | 3 | 1987 | 4774 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1992 | 2414 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1978 | 542 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 14201 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1984 | 98 | 0.010 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2004 | 35 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 2004 | 109 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2006 | 492 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3810 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1985 | 389 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10765 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1994 | 2905 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1992 | 4148 | 0.010 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1982 | 52 | 0.010 |
Why?
|
| Isoantigens | 1 | 1985 | 562 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1982 | 109 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1982 | 123 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1988 | 535 | 0.010 |
Why?
|
| Cattle | 2 | 1994 | 3819 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1983 | 1356 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 27453 | 0.010 |
Why?
|
| Encephalitis | 1 | 1985 | 441 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2006 | 880 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1982 | 251 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1982 | 262 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1987 | 1676 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 1982 | 328 | 0.010 |
Why?
|
| Sodium Cyanide | 1 | 1980 | 9 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 9519 | 0.010 |
Why?
|
| Naphthols | 1 | 1980 | 46 | 0.010 |
Why?
|
| Apoproteins | 1 | 1980 | 45 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 1980 | 112 | 0.010 |
Why?
|
| Free Radicals | 1 | 1980 | 238 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1980 | 242 | 0.010 |
Why?
|
| Catalase | 1 | 1980 | 215 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1982 | 1336 | 0.010 |
Why?
|
| Prostaglandins H | 1 | 1978 | 23 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4506 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3813 | 0.010 |
Why?
|
| Antibody Formation | 2 | 1981 | 1393 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1987 | 1266 | 0.010 |
Why?
|
| Catalysis | 1 | 1980 | 768 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1983 | 1439 | 0.010 |
Why?
|
| Iron | 2 | 1977 | 1814 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1985 | 1361 | 0.010 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1977 | 64 | 0.010 |
Why?
|
| Carcinoma | 1 | 1989 | 2340 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1982 | 1150 | 0.010 |
Why?
|
| Apoenzymes | 1 | 1976 | 14 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2543 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7453 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 1428 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1980 | 559 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1976 | 199 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1976 | 292 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1999 | 572 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1990 | 6611 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 2251 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1980 | 1441 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1979 | 2226 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1983 | 510 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18354 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1992 | 152 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1982 | 421 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1992 | 318 | 0.010 |
Why?
|
| Monocytes | 1 | 1981 | 2603 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 283 | 0.010 |
Why?
|
| Myeloma Proteins | 2 | 1981 | 71 | 0.010 |
Why?
|
| Immune Sera | 2 | 1981 | 605 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1985 | 3250 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1992 | 656 | 0.010 |
Why?
|
| Pregnancy | 2 | 1990 | 30265 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1990 | 425 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1989 | 66 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1987 | 76 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 354 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1305 | 0.000 |
Why?
|
| Chromosome Mapping | 2 | 1984 | 4625 | 0.000 |
Why?
|
| Pulmonary Alveoli | 1 | 1988 | 665 | 0.000 |
Why?
|
| Blood Cells | 1 | 1987 | 309 | 0.000 |
Why?
|
| Chromosomes, Human, 4-5 | 1 | 1984 | 26 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 69 | 0.000 |
Why?
|
| Karyotyping | 1 | 1984 | 1177 | 0.000 |
Why?
|
| Hybridomas | 1 | 1982 | 444 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1981 | 312 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1983 | 609 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1982 | 716 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 152 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1982 | 828 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1981 | 530 | 0.000 |
Why?
|
| Growth Substances | 1 | 1980 | 760 | 0.000 |
Why?
|
| Lipoxygenase | 1 | 1977 | 72 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1984 | 2604 | 0.000 |
Why?
|
| Malondialdehyde | 1 | 1977 | 113 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1980 | 681 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1981 | 1082 | 0.000 |
Why?
|
| Platelet Aggregation | 1 | 1977 | 769 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1981 | 2614 | 0.000 |
Why?
|
| Leukemia | 1 | 1981 | 1520 | 0.000 |
Why?
|
| Smoking | 1 | 1988 | 9094 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1981 | 3116 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1981 | 3626 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8745 | 0.000 |
Why?
|
| Infant | 1 | 1983 | 36556 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1983 | 42683 | 0.000 |
Why?
|
| Child | 1 | 1983 | 80960 | 0.000 |
Why?
|
| Adolescent | 1 | 1983 | 89244 | 0.000 |
Why?
|
| Middle Aged | 1 | 1983 | 223737 | 0.000 |
Why?
|
| Adult | 1 | 1983 | 223851 | 0.000 |
Why?
|